Metabolism
Serine/threonine kinase AMPK upregulates glucose uptake by promoting the expression and function of glucose transporters. AMPK is activated by increased AMP/ATP ratio, resulting from cellular and environmental stress, e.g. low glucose, heat shock, hypoxia and ischemia. AMPK activation positively modulates signaling transductions that refill ATP levels. Moreover, it also stimulates catabolic processes such as fatty acid oxidation and glycolysis through inhibition of ACC and activation of PFK2. AMPK negatively regulates various proteins which are important to ATP-consuming mechanisms, e.g. mTORC2, glycogen synthase, SREBP-1, and TSC2, causing the downregulation/inhibition of gluconeogenesis and glycogen, lipid and protein synthesis.
-
B4987 Liproxstatin-11 CitationSummary: A potent ferroptosis inhibitor
-
B5823 LP533401 hclTarget: TphSummary: Tph-1 inhibitor
-
B5963 7-EthoxyresorufinTarget: Cytochrome P450 (CYP450)Summary: Specific subtrate of CYP1A
-
C5414 TPPUTarget: epoxide hydrolaseSummary: potent inhibitor of both human and mouse sEH
-
B5354 CGP 3466B maleateTarget: GAPDHSummary: GAPDH inhibitor
-
B5508 Alda 1Target: Aldehyde DehydrogenasesSummary: ALDH2 activator
-
B7794 BMS 3094032 CitationTarget: Fatty-acid-binding proteins (FABPs)Summary: FABP4 inhibitor,potent and selective
-
B4900 Indoximod (NLG-8189)Summary: Indoleamine 2,3-dioxygenase (IDO) pathway inhibitor
-
B6988 BRL 50481Target: Phosphodiesterases (PDEs)Summary: PDE7 inhibitor,potent and selective
-
B7417 Tunicamycin1 CitationSummary: antibiotic,inhibits GlcNAc phosphotransferase (GPT)